These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26893245)

  • 1. The potential of protein-based nanocages for imaging and drug delivery.
    Corsi F; Mazzucchelli S
    Ther Deliv; 2016; 7(3):149-51. PubMed ID: 26893245
    [No Abstract]   [Full Text] [Related]  

  • 2. Functionalization of protein-based nanocages for drug delivery applications.
    Schoonen L; van Hest JC
    Nanoscale; 2014 Jul; 6(13):7124-41. PubMed ID: 24860847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redesign of protein nanocages: the way from 0D, 1D, 2D to 3D assembly.
    Lv C; Zhang X; Liu Y; Zhang T; Chen H; Zang J; Zheng B; Zhao G
    Chem Soc Rev; 2021 Mar; 50(6):3957-3989. PubMed ID: 33587075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functionalized protein nanocages as a platform of targeted therapy and immunodetection.
    Ghisaidoobe AB; Chung SJ
    Nanomedicine (Lond); 2015; 10(24):3579-95. PubMed ID: 26651131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein nanoparticles for therapeutic protein delivery.
    Herrera Estrada LP; Champion JA
    Biomater Sci; 2015 Jun; 3(6):787-99. PubMed ID: 26221839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system.
    Bamrungsap S; Zhao Z; Chen T; Wang L; Li C; Fu T; Tan W
    Nanomedicine (Lond); 2012 Aug; 7(8):1253-71. PubMed ID: 22931450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioengineered protein-based nanocage for drug delivery.
    Lee EJ; Lee NK; Kim IS
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):157-171. PubMed ID: 26994591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long-term delivery of proteins and peptides using micro/nanoparticles: overview and perspectives.
    Ye C; Venkatraman S
    Ther Deliv; 2019 May; 10(5):269-272. PubMed ID: 31094301
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-angiogenic perfluorocarbon nanoparticles for diagnosis and treatment of atherosclerosis.
    Caruthers SD; Cyrus T; Winter PM; Wickline SA; Lanza GM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(3):311-23. PubMed ID: 20049799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mathematical modeling of the protein corona: implications for nanoparticulate delivery systems.
    Dell'Orco D; Lundqvist M; Linse S; Cedervall T
    Nanomedicine (Lond); 2014 May; 9(6):851-8. PubMed ID: 24981650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endowing a ferritin-like cage protein with high affinity and selectivity for certain inorganic materials.
    Sano K; Ajima K; Iwahori K; Yudasaka M; Iijima S; Yamashita I; Shiba K
    Small; 2005 Aug; 1(8-9):826-32. PubMed ID: 17193533
    [No Abstract]   [Full Text] [Related]  

  • 12. Designing drug-delivery systems for the nervous system using nanotechnology: opportunities and challenges.
    Liu-Snyder P; Webster TJ
    Expert Rev Med Devices; 2006 Nov; 3(6):683-7. PubMed ID: 17280531
    [No Abstract]   [Full Text] [Related]  

  • 13. Inorganic nanoparticles for cancer imaging and therapy.
    Huang HC; Barua S; Sharma G; Dey SK; Rege K
    J Control Release; 2011 Nov; 155(3):344-57. PubMed ID: 21723891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-drug conjugates: targeting melanoma with cisplatin encapsulated in protein-cage nanoparticles based on human ferritin.
    Falvo E; Tremante E; Fraioli R; Leonetti C; Zamparelli C; Boffi A; Morea V; Ceci P; Giacomini P
    Nanoscale; 2013 Dec; 5(24):12278-85. PubMed ID: 24150593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery.
    Tan ML; Choong PF; Dass CR
    Peptides; 2010 Jan; 31(1):184-93. PubMed ID: 19819278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation-synthesized protein-based drug carriers: Size-controlled BSA nanoparticles.
    Queiroz RG; Varca GH; Kadlubowski S; Ulanski P; Lugão AB
    Int J Biol Macromol; 2016 Apr; 85():82-91. PubMed ID: 26730485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleoside-lipid-based nanoparticles for cisplatin delivery.
    Khiati S; Luvino D; Oumzil K; Chauffert B; Camplo M; Barthélémy P
    ACS Nano; 2011 Nov; 5(11):8649-55. PubMed ID: 21961944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.
    Hallan SS; Kaur P; Kaur V; Mishra N; Vaidya B
    Artif Cells Nanomed Biotechnol; 2016; 44(1):334-49. PubMed ID: 25237838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reinvention of chemotherapy: drug conjugates and nanoparticles.
    Nguyen-Ngoc T; Raymond E
    Curr Opin Oncol; 2015 May; 27(3):232-42. PubMed ID: 25783982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in targeting strategies for nanoparticles in cancer imaging and therapy.
    Yhee JY; Lee S; Kim K
    Nanoscale; 2014 Nov; 6(22):13383-90. PubMed ID: 25273283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.